01Dec
Covid–19 coronavirus: global merger review
Merger review processes are being impacted worldwide as merger control authorities adapt to take account of the consequences of Covid-19 coronavirus. While critical transactions are likely to be reviewed, as far as possible, in accordance with normal practice, many cases may face changes in approach and practice (eg extensions of timelines in certain circumstances). See our overview for an indication of the different approaches being taken by authorities around the world. Please see full...
By:
Allen & Overy LLP
Related
As previously noted, the Supreme Court has identified that there are issues with the Commonwealth Co...
Read More >
The New York State Senate and Assembly on June 19 passed Bill 8421 (the Bill), which lowers the stan...
Read More >
On October 10, 2019, California Governor Newsom signed a bill seeking to ban employers from requirin...
Read More >
You expect your insurance carrier to provide coverage when a claim is made against your company. How...
Read More >
On November 22nd, the CFPB issued a press release announcing that a stipulated final judgment and or...
Read More >
What happens when legislative efforts are met with focused pressure from a variety of industries, ci...
Read More >